Featured News
More News
Stanford Clinicians Find Greater Incidence of Obesity and Eating Disorders Among Young People Because of the COVID-19 Pandemic
The COVID-19 pandemic has led to a greater incidence of obesity and eating disorders among young people, according to experts at Stanford Children’s Health.
Digital health tracking tools help individuals lose weight, study finds
Digital health tools, such as diet-tracking apps, increase engagement in weight loss programs, helping users shed pounds, according to a new study.
Dr. Seung Kim, Director of SDRC, has been elected to the Association of American Physicians
Congratulations to Seung Kim as he has been elected to the Association of American Physicians.
SDRC investigators team up to create a new device that can perform blood tests continually
The new device can continuously sense levels of virtually any protein or molecule in the blood. The researchers say it could be transformative for disease detection, patient monitoring and biomedical research.
SDRC investigators find evidence in CREDENCE clinical trial for efficacy and safety of canagliflozin for type2 diabetes
Sun Kim, MD, MS, associate professor of endocrinology, was a principal investigator at Stanford for a recent randomized, placebo-controlled clinical trial of the drug canagliflozin, which is a sodium glucose co-transporter 2 inhibitor.
Using an AI-based algorithm, Katrin Svensson, PhD, and lead researcher Laetitia Coassolo, PhD, identified a 12-amino acid peptide that suppresses appetite and promotes weight loss in mice and minipigs by activating different metabolic and neuronal pathways than GLP-1.